It could be further hypothesized that genetic mutants that obstructed normal functioning of TLR4 were another pivotal contributors for risk and poor prognosis of BPH, and our study has confirmed this within a Chinese population (Table 2-5). The gene discussed is TLR4; the disease is benign prostatic hyperplasia.